The Clinical Research Design, Epidemiology, and Biostatistics (CRDEB) KCA will play a crucial role in achieving the CTR-IN goal of accelerating the translation of scientific discovery into improved health by creating a coordinated infrastructure encouraging innovative clinical and translational research and enhancing our training of new and established researchers. The majority of MWRC partner institutions recognize that clinical research design, epidemiology, and biostatistics are critical to investigation, from initial study design through data analysis and the effective communication of results. As a result, a number of independent efforts in these areas exist throughout the MWRC and operate somewhat autonomously. However, multiple barriers to access exist for some researchers. While many successful and established researchers have access to these groups, other investigator's access may be limited and haphazard, particularly for more junior researchers. In addition, there is no coordinated system that provides such support to investigators. Also, the fractured nature and geographical barriers of the Mountain West have impaired the effective integration and dissemination of clinical research design, epidemiology, and biostatistics support, collaboration, and training. In order to overcome these barriers, the CTR-IN will provide local and central contact points for clinical and translational researchers who need assistance in developing study design, biostatistical methods, and epidemiological design. This will foster an energetic and productive climate for clinical and translational research and facilitate research for all investigators, including new and junior investigators.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-TWD-C (CC))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Nevada Las Vegas
Las Vegas
United States
Zip Code
Agarwal, Andrea B; Feng, Cheng-Yuan; Altick, Amy L et al. (2016) Altered Protein Composition and Gene Expression in Strabismic Human Extraocular Muscles and Tendons. Invest Ophthalmol Vis Sci 57:5576-5585
Davis, James; Tam, Elizabeth; Taira, Deborah (2016) Disparate Rates of Utilization and Progression to Combined Heart Failure and Chronic Obstructive Pulmonary Disease among Asians and Pacific Islanders in Hawai'i. Hawaii J Med Public Health 75:228-34
Izuora, Kenneth E; Ezeanolue, Echezona E; Neubauer, Michael F et al. (2016) Changes in Inflammatory and Bone Turnover Markers After Periodontal Disease Treatment in Patients With Diabetes. Am J Med Sci 351:589-94
Obana, Kyle K; Davis, James (2016) Racial Disparities in the Prevalence of Arthritis among Native Hawaiians and Pacific Islanders, Whites, and Asians. Hawaii J Med Public Health 75:155-61
Izuora, Kenneth E; Ezeanolue, Echezona E; Neubauer, Michael F et al. (2016) DENTAL LOSS AMONG AMBULATORY PATIENTS WITH DIABETES. J Clin Transl Endocrinol 4:28-31
Amatya, Anup; Demirtas, Hakan (2016) Concurrent generation of multivariate mixed data with variables of dissimilar types. J Stat Comput Simul 86:3595-3607
Shan, Guogen; Zhang, Hua; Jiang, Tao et al. (2016) Exact p-values for Simon's two-stage designs in clinical trials. Stat Biosci 8:351-357
Wang, Haizhou; Leung, Ming; Wandinger-Ness, Angela et al. (2016) Constrained inference of protein interaction networks for invadopodium formation in cancer. IET Syst Biol 10:76-85
Shan, Guogen; Zhang, Hua; Jiang, Tao (2016) Minimax and admissible adaptive two-stage designs in phase II clinical trials. BMC Med Res Methodol 16:90
Shan, Guogen; Wilding, Gregory E; Hutson, Alan D et al. (2016) Optimal adaptive two-stage designs for early phase II clinical trials. Stat Med 35:1257-66

Showing the most recent 10 out of 29 publications